Zagryazhskaya et al. [23] demonstrated that the downregulation of S100A11 using RNA interference markedly increases the vulnerability of non-small cell lung cancer cells to oxaliplatin, 5-fluorouracil, and cisplatin. The gene discussed is S100A11; the disease is non-small cell lung carcinoma.